Akynzeo 300-0.5 MG capsules
Ended Awarded
- Contract number
- SPE2DB25FJZ61
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,086
Award facts
- Contract value 100% obligated
- $50,086.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50,086.37 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for AKYNZEO 300-0.5 mg capsules, with a completion date of September 19, 2025. This non-set-aside competitive award will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AKYNZEO is an antiemetic medication commonly used to prevent chemotherapy-induced nausea and vomiting in oncology patients. The award reflects AmerisourceBergen's established capability to fulfill federal medical supply requirements through competitive procurement, consistent with its portfolio of delivery orders covering diabetes medications, neurological treatments, pain management pharmaceuticals, vaccines, and specialized medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FJZ61?
SPE2DB25FJZ61 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FJZ61 worth?
The government has obligated $50,086 on SPE2DB25FJZ61.
Is contract SPE2DB25FJZ61 an order under another contract?
Yes. SPE2DB25FJZ61 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJZ61 competed?
The extent of competition for SPE2DB25FJZ61 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award